Sotera Health Company (SHC) Stock Analysis & Winston Score

Sotera Health makes hospitals and medical device companies confident that their products are safe to use. It does this by sterilizing medical equipment — things like surgical tools, syringes, and implants — so they are free of harmful bacteria before reaching patients. The company operates through its main business, Sterigenics, which is one of the largest contract sterilization providers in the world, along with lab testing and advisory services under the Nordion and Nelson Labs brands. Sotera makes money by charging healthcare manufacturers a fee each time their products are sterilized or tested. It operates across North America, Europe, and Asia, generating roughly $1 billion in annual revenue. Its moat comes from the high cost and regulatory complexity of building sterilization facilities, which makes it hard for new competitors to enter. The key risk the company faces is ongoing legal and regulatory scrutiny around ethylene oxide, a sterilization gas linked to health concerns in communities near its facilities.